Information de reference pour ce titreAccession Number: | 00006615-201810000-00001.
|
Author: | Fakhri, Sajad a; Abbaszadeh, Fatemeh b; Dargahi, Leila c; Jorjani, Masoumeh a,b,*
|
Institution: | (a)Department of Pharmacology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran (b)Neurobiology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran (c)Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
|
Title: | Astaxanthin: A mechanistic review on its biological activities and health benefits.[Article]
|
Source: | Pharmacological Research. 136:1-20, October 2018.
|
Abstract: | Astaxanthin (AST) is a potent lipid-soluble keto-carotenoid with auspicious effects on human health. It protects organisms against a wide range of diseases with excellent safety and tolerability. Various imperative biological activities in vitro and in vivo models have been suggested for AST.
This review article is focused on the therapeutic potentials, biological activities and benefical health effects of AST. The pharmacological mechanisms of action of AST in the treatment and prevention of the peripheral and central nervous system diseases was also reviewed to provide new insights to researchers. Finally, we suggested a novel hypothesis for the mechanism of action of AST in neuropathic pain following spinal cord injury.
(C) 2018Elsevier, Inc.
|
Author Keywords: | Astaxanthin (PubChem CID: 5368397); Beta-Carotene (PubChem CID: 5280489); Beta-Cryptoxanthin (PubChem CID: 5281235); Canthaxanthin (PubChem CID: 5281227); Lutein (PubChem CID: 5281243); Zeaxanthin (PubChem CID: 5280899); Alpha-Tocopherol (PubChem CID: 14985); Azoxymethane (PubChem CID: 33184); Astaxanthin; Pharmacology; Biological activities; Health benefits.
|
References: | [1] Baralic I, Andjelkovic M, Djordjevic B, Dikic N, Radivojevic N, Suzin-Zivkovic V, Radojevic-Skodric S, Pejic S. Effect of astaxanthin supplementation on salivary IgA, oxidative stress, and inflammation in young soccer players. Evid. Complement. Altern. Med. 2015;2015:1-9.
[2] Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP. Effect of astaxanthin supplementation on inflammation and cardiac function in BALB/c mice. Anticancer Res. 2010;30(7):2721-2725.
[3] Hu J, Nagarajan D, Zhang Q, Chang J-S, Lee D-J. Heterotrophic cultivation of microalgae for pigment production: a review. Biotechnol. Adv. 2017;54-67.
[4] Bjerkeng B, Peisker M, Von Schwartzenberg K, Ytrest[phi]yl T, Asgard T. Digestibility and muscle retention of astaxanthin in Atlantic salmon, Salmo salar, fed diets with the red yeast Phaffia rhodozyma in comparison with synthetic formulated astaxanthin. Aquaculture. 2007;269(1-4):476-489.
[5] Tume R, Sikes A, Tabrett S, Smith D. Effect of background colour on the distribution of astaxanthin in black tiger prawn (Penaeus monodon): effective method for improvement of cooked colour. Aquaculture. 2009;296(1-2):129-135.
[6] Seabra LMAJ, Pedrosa LFC. Astaxanthin: structural and functional aspects. Revista de Nutricao. 2010;23(6):1041-1050.
[7] Zheng YF, Bae SH, Kwon MJ, Park JB, Choi HD, Shin WG, Bae SK. Inhibitory effects of astaxanthin, [beta]-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities. Food Chem. Toxicol. 2013;59:78-85.
[8] Sueishi Y, Ishikawa M, Yoshioka D, Endoh N, Oowada S, Shimmei M, Fujii H, Kotake Y. Oxygen radical absorbance capacity (ORAC) of cyclodextrin-solubilized flavonoids, resveratrol and astaxanthin as measured with the ORAC-EPR method. J. Clin. Biochem. Nutr. 2012;50(2):127-132.
[9] Zaripheh S, Erdman JW. Factors that influence the bioavailablity of xanthophylls. J. Nutr. 2002;132(3):531S-534S.
[10] Wang C, Armstrong DW, Chang C-D. Rapid baseline separation of enantiomers and a mesoform of all-trans-astaxanthin, 13-cis-astaxanthin, adonirubin, and adonixanthin in standards and commercial supplements. J. Chromatogr. A. 2008;1194(2):172-177.
[11] Stewart JS, Lignell A, Pettersson A, Elfving E, Soni M. Safety assessment of astaxanthin-rich microalgae biomass: acute and subchronic toxicity studies in rats. Food Chem. Toxicol. 2008;46(9):3030-3036.
[12] Miki W. Biological functions and activities of animal carotenoids. Pure Appl. Chem. 1991;63(1):141-146.
[13] Matsuno T. Xanthophylls as precursors of retinoids. Pure Appl. Chem. 1991;63(1):81-88.
[14] Nguyen TT, Barber AR, Corbin K, Zhang W. Lobster processing by-products as valuable bioresource of marine functional ingredients, nutraceuticals, and pharmaceuticals. Bioresour. Bioprocess. 2017;4(1):27.
[15] Yamashita E. Astaxanthin as a medical food. Funct. Foods Health Dis. 2013;3(7):254-258.
[16] Ambati RR, Phang S-M, Ravi S, Aswathanarayana RG. Astaxanthin: sources, extraction, stability, biological activities and its commercial applications-a review. Mar. Drugs. 2014;12(1):128-152.
[17] Balietti M, Giannubilo SR, Giorgetti B, Solazzi M, Turi A, Casoli T, Ciavattini A, Fattorettia P. The effect of astaxanthin on the aging rat brain: gender-related differences in modulating inflammation. J. Sci. Food Agric. 2016;96(2):615-618.
[18] Higuera-Ciapara I, Felix-Valenzuela L, Goycoolea F. Astaxanthin: a review of its chemistry and applications. Crit. Rev. Food Sci. Nutr. 2006;46(2):185-196.
[19] Edwards JA, Bellion P, Beilstein P, Rumbeli R, Schierle J. Review of genotoxicity and rat carcinogenicity investigations with astaxanthin. Regul. Toxicol. Pharmacol. 2016;75:5-19.
[20] Turujman SA, Wamer WG, Wei RR, Albert RH. Rapid liquid chromatographic method to distinguish wild salmon from aquacultured salmon fed synthetic astaxanthin. J. AOAC Int. 1997;80(3):622-632.
[21] Sachindra N, Bhaskar N, Siddegowda G, Sathisha A, Suresh P. Recovery of carotenoids from ensilaged shrimp waste. Bioresour. Technol. 2007;98(8):1642-1646.
[22] Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern. Med. Rev. 2011;16(4):355-364.
[23] Boussiba S, Bing W, Yuan J-P, Zarka A, Chen F. Changes in pigments profile in the green alga Haeamtococcus pluvialis exposed to environmental stresses. Biotechnol. Lett. 1999;21(7):601-604.
[24] Satoh A, Tsuji S, Okada Y, Murakami N, Urami M, Nakagawa K, Ishikura M, Katagiri M, Koga Y, Shirasawa T. Preliminary clinical evaluation of toxicity and efficacy of a new astaxanthin-rich Haematococcus pluvialis extract. J. Clin. Biochem. Nutr. 2009;44(3):280-284.
[25] Yuan JP, Peng J, Yin K, Wang JH. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 2011;55(1):150-165.
[26] Yuan J-P, Chen F, Liu X, Li X-Z. Carotenoid composition in the green microalga Chlorococcum. Food Chem. 2002;76(3):319-325.
[27] Affandi M, Julianto T, Majeed A. Development and stability evaluation of astaxanthin nanoemulsion. Asian J. Pharm. Clin. Res. 2011;4(1):142-148.
[28] Boussiba S. Carotenogenesis in the green alga Haematococcus pluvialis: cellular physiology and stress response. Physiol. Plant. 2000;108(2):111-117.
[29] Mosaad YO, Abd El Khalik Gobba N, Hussein MA. Astaxanthin; a Promising Protector against gentamicin-induced nephrotoxicity in rats. Curr. Pharm. Biotechnol. 2016;17(13):1189-1197.
[30] Palozza P, Krinsky NI. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 1992;297(2):291-295.
[31] Kurashige M, Okimasu E, Inoue M, Utsumi K. Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR. 1990;22(1):27-38.
[32] Curek GD, Cort A, Yucel G, Demir N, Ozturk S, Elpek GO, Savas B, Aslan M. Effect of astaxanthin on hepatocellular injury following ischemia/reperfusion. Toxicology. 2010;267(1-3):147-153.
[33] Martin HD, Jager C, Ruck C, Schmidt M, Walsh R, Paust J. Anti-and prooxidant properties of carotenoids. Adv. Synth. Catal. 1999;341(3):302-308.
[34] McNulty HP, Byun J, Lockwood SF, Jacob RF, Mason RP. Differential effects of carotenoids on lipid peroxidation due to membrane interactions: X-ray diffraction analysis. Biochim. et Biophys. Acta (BBA)-Biomembr. 2007;1768(1):167-174.
[35] Iwamoto T, Hosoda K, Hirano R, Kurata H, Matsumoto A, Miki W, Kamiyama M, Itakura H, Yamamoto S, Kondo K. Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atheroscler. Thromb. 2000;7(4):216-222.
[36] Kopec RE, Cooperstone JL, Cichon MJ, Schwartz SJ. Analysis Methods of Carotenoids, Analysis of Antioxidant-Rich Phytochemicals. 2012. Wiley-Blackwell. Hoboken: Chichester. 105-149.
[37] Tzanova M, Argirova M, Atanasov V. HPLC Quantification of astaxanthin and canthaxanthin in Salmonidae eggs. Biomed. Chromatogr. 2017;31(4), e3852
[38] Gentili A, Caretti F, Bellante S, Ventura S, Canepari S, Curini R. Comprehensive profiling of carotenoids and fat-soluble vitamins in milk from different animal species by LC-DAD-MS/MS hyphenation. J. Agric. Food Chem. 2012;61(8):1628-1639.
[39] Gentili A, Caretti F. Evaluation of a method based on liquid chromatography-diode array detector-tandem mass spectrometry for a rapid and comprehensive characterization of the fat-soluble vitamin and carotenoid profile of selected plant foods. J. Chromatogr. A. 2011;1218(5):684-697.
[40] Chen J, Wei D, Pohnert G. Rapid estimation of astaxanthin and the carotenoid-to-chlorophyll ratio in the green microalga Chromochloris zofingiensis using flow cytometry. Mar. Drugs. 2017;15(7):231.
[41] Edge R, McGarvey D, Truscott T. The carotenoids as anti-oxidants-a review. J. Photochem. Photobiol. B Biol. 1997;41(3):189-200.
[42] Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007;39(1):44-84.
[43] Wu H, Niu H, Shao A, Wu C, Dixon BJ, Zhang J, Yang S, Wang Y. Astaxanthin as a potential neuroprotective agent for neurological diseases. Mar. Drugs. 2015;13(9):5750-5766.
[44] Najafi H, Ashtiyani S, Madani SH, Fakhri S, Yarijani Z, Hazem M. Therapeutic effects of Curcumin on renal tissue damages induced by ischemia reperfusion in rat. Koomesh. 16 (2), 2015.
[45] Najafi H, Ashtiyani SC, Sayedzadeh SA. Therapeutic effects of curcumin on the functional disturbances and oxidative stress induced by renal ischemia/reperfusion in rats. Avicenna J. Phytomed. 2015;5(6):576.
[46] Heidari Khoei H, Fakhri S, Parvardeh S, Shams Mofarahe Z, Ghasemnejad-Berenji H, Nazarian H, Baninameh Z. Testicular toxicity and reproductive performance of streptozotocin-induced diabetic male rats: the ameliorating role of silymarin as an antioxidant. Toxin Rev. 2018;1-11.
[47] Britton G. Structure and properties of carotenoids in relation to function. FASEB J. 1995;9(15):1551-1558.
[48] Kamath BS, Srikanta BM, Dharmesh SM, Sarada R, Ravishankar GA. Ulcer preventive and antioxidative properties of astaxanthin from Haematococcus pluvialis. Eur. J. Pharmacol. 2008;590(1-3):387-395.
[49] Rao AR, Sindhuja H, Dharmesh SM, Sankar KU, Sarada R, Ravishankar GA. Effective inhibition of skin cancer, tyrosinase, and antioxidative properties by astaxanthin and astaxanthin esters from the green alga Haematococcus pluvialis. J. Agric. Food Chem. 2013;61(16):3842-3851.
[50] Augusti PR, Quatrin A, Somacal S, Conterato GM, Sobieski R, Ruviaro AR, Maurer LH, Duarte MM, Roehrs M, Emanuelli T. Astaxanthin prevents changes in the activities of thioredoxin reductase and paraoxonase in hypercholesterolemic rabbits. J. Clin. Biochem. Nutr. 2012;51(1):42-49.
[51] Liu X, Osawa T. Cis astaxanthin and especially 9-cis astaxanthin exhibits a higher antioxidant activity in vitro compared to the all-trans isomer. Biochem. Biophys. Res. Commun. 2007;357(1):187-193.
[52] Nakajima Y, Inokuchi Y, Shimazawa M, Otsubo K, Ishibashi T, Hara H. Astaxanthin, a dietary carotenoid, protects retinal cells against oxidative stress in-vitro and in mice in-vivo. J. Pharm. Pharmacol. 2008;60(10):1365-1374.
[53] Naguib YM. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000;48(4):1150-1154.
[54] Iwasaki T, Tawara A. Effects of astaxanthin on eyestrain induced by accommodative dysfunction. J. Eye. 2006;23(6):829.
[55] Yamashita E. Let astaxanthin be thy medicine. Pharma Nutr. 2015;3(4):115-122.
[56] Shimidzu N, Goto M, Miki W. Carotenoids as singlet oxygen quenchers in marine organisms. Fish. Sci. 1996;62(1):134-137.
[57] Dong S, Huang Y, Zhang R, Wang S, Liu Y. Four different methods comparison for extraction of astaxanthin from green alga Haematococcus pluvialis. Sci. World J. 2014;2014:1-7.
[58] Dong S, Huang Y, Zhang R, Lian Z, Wang S, Liu Y. Inclusion complexes of astaxanthin with hydroxypropyl-[beta]-cyclodextrin: parameters optimization, spectroscopic profiles, and properties. Eur. J. Lipid Sci. Technol. 2014;116(8):978-986.
[59] Ranga Rao A., 2011. Production of Astaxanthin From Cultured Green Alga Haematococcus pluvialis and Its Biological Activities, University of Mysore.
[60] Seya Y, Takahashi J, Imanaka K. Relationship between visual and reaction times-effects of a repetition of a visual task and long-term intake of a supplement food including astaxanthin on reaction time-Japanese. J. Physiol. Anthropol. 2009;14:17-24.
[61] Chew BP, Mathison BD, Hayek MG, Massimino S, Reinhart GA, Park JS. Dietary astaxanthin enhances immune response in dogs. Vet. Immunol. Immunopathol. 2011;140(3-4):199-206.
[62] Liu X, Luo Q, Rakariyatham K, Cao Y, Goulette T, Liu X, Xiao H. Antioxidation and anti-ageing activities of different stereoisomeric astaxanthin in vitro and in vivo. J. Funct. Foods. 2016;25:50-61.
[63] Al-Amin MM, Akhter S, Hasan AT, Alam T, Hasan SN, Saifullah A, Shohel M. The antioxidant effect of astaxanthin is higher in young mice than aged: a region specific study on brain. Metab. Brain Dis. 2015;30(5):1237-1246.
[64] Liang J, Tian Y-X, Yang F, Zhang J-P, Skibsted LH. Antioxidant synergism between carotenoids in membranes. Astaxanthin as a radical transfer bridge. Food Chem. 2009;115(4):1437-1442.
[65] Nagaraj S, Rajaram M, Arulmurugan P, Baskaraboopathy A, Karuppasamy K, Jayappriyan K, Sundararaj R, Rengasamy R. Antiproliferative potential of astaxanthin-rich alga Haematococcus pluvialis Flotow on human hepatic cancer (HepG2) cell line. Biomed. Prev. Nutr. 2012;2(3):149-153.
[66] Guerin M, Huntley ME, Olaizola M. Haematococcus astaxanthin: applications for human health and nutrition. Trends Biotechnol. 2003;21(5):210-216.
[67] Ye Q, Zhang X, Huang B, Zhu Y, Chen X. Astaxanthin suppresses MPP+-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar. Drugs. 2013;11(4):1019-1034.
[68] Wu Q, Zhang X-S, Wang H-D, Zhang X, Yu Q, Li W, Zhou M-L, Wang X-L. Astaxanthin activates nuclear factor erythroid-related factor 2 and the antioxidant responsive element (Nrf2-ARE) pathway in the brain after subarachnoid hemorrhage in rats and attenuates early brain injury. Mar. Drugs. 2014;12(12):6125-6141.
[69] Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y, Hou D, Zhang X. Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol. Vis. 2013;19:1656-1666.
[70] Wang H-Q, Sun X-B, Xu Y-X, Zhao H, Zhu Q-Y, Zhu C-Q. Astaxanthin upregulates heme oxygenase-1 expression through ERK1/2 pathway and its protective effect against beta-amyloid-induced cytotoxicity in SH-SY5Y cells. Brain Res. 2010;1360:159-167.
[71] Heidari Khoei H, Fakhri S, Parvardeh S, Shams Mofarahe Z, Baninameh Z, Vardiani M. Astaxanthin prevents the methotrexate-induced reproductive toxicity by targeting oxidative stress in male mice. Toxin Rev. 2018;1-7.
[72] Ranga Rao A, Raghunath Reddy R, Baskaran V, Sarada R, Ravishankar G. Characterization of microalgal carotenoids by mass spectrometry and their bioavailability and antioxidant properties elucidated in rat model. J. Agric. Food Chem. 2010;58(15):8553-8559.
[73] Turrin NP, Rivest S. Molecular and cellular immune mediators of neuroprotection. Mol. Neurobiol. 2006;34(3):221-242.
[74] Brown GC, Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol. Neurobiol. 2010;41(2-3):242-247.
[75] Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147 (S1), 2006.
[76] Bennedsen M, Wang X, Willen R, Wadstrom T, Andersen LP. Treatment of H. Pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 2000;70(3):185-189.
[77] Suzuki Y, Ohgami K, Shiratori K, Jin X-H, Ilieva I, Koyama Y, Yazawa K, Yoshida K, Kase S, Ohno S. Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-[kappa]B signaling pathway. Exp. Eye Res. 2006;82(2):275-281.
[78] Speranza L, Pesce M, Patruno A, Franceschelli S, Lutiis M.Ad, Grilli A, Felaco M. Astaxanthin treatment reduced oxidative induced pro-inflammatory cytokines secretion in U937: SHP-1 as a novel biological target. Mar. Drugs. 2012;10(4):890-899.
[79] Ghosh S, May MJ, Kopp EB. NF-[kappa]B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998;16(1):225-260.
[80] Alnemri E. Activation of the Ikappa B kinases by RIP via IKKgamma, NEMO-Mediated; 2000.
[81] Shao AW, Wu HJ, Chen S, Ammar Ab, Zhang JM, Hong Y. Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-[kappa]B-dependent inflammatory/MMP-9 pathway. CNS Neurosci. Ther. 2014;20(2):182-185.
[82] Bhuvaneswari S, Yogalakshmi B, Sreeja S, Anuradha CV. Astaxanthin reduces hepatic endoplasmic reticulum stress and nuclear factor-[kappa]B-mediated inflammation in high fructose and high fat diet-fed mice. Cell Stress Chaperones. 2014;19(2):183-191.
[83] Choi S-K, Park Y-S, Choi D-K, Chang H-I. Effects of astaxanthin on the production of NO and the expression of COX-2 and iNOS in LPS-stimulated BV2 microglial cells. J. Microbiol. Biotechnol. 2008;18(12):1990-1996.
[84] Nakano M, Onodera A, Saito E, Tanabe M, Yajima K, Takahashi J, Van Chuyen N. Effect of astaxanthin in combination with [alpha]-tocopherol or ascorbic acid against oxidative damage in diabetic ODS rats. J. Nutr. Sci. Vitaminol. 2008;54(4):329-334.
[85] Ohgami K, Shiratori K, Kotake S, Nishida T, Mizuki N, Yazawa K, Ohno S. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 2003;44(6):2694-2701.
[86] Rao AR, Reddy AH, Aradhya S. Antibacterial properties of Spirulina platensis, Haematococcus pluvialis, Botryococcus braunii micro algal extracts. Curr. Trends Biotechnol. Pharm. 2010;4(3):809-819.
[87] Liu B, Lee Y. Effect of total secondary carotenoids extracts from Chlorococcum sp. on Helicobacter pylori-infected BALB/c mice. Int. Immunopharmacol. 2003;3(7):979-986.
[88] Kam P, Ferch N. Apoptosis: mechanisms and clinical implications. Anaesthesia. 2000;55(11):1081-1093.
[89] Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007;35(4):495-516.
[90] Zhang L, Wang H. Multiple mechanisms of anti-cancer effects exerted by astaxanthin. Mar. Drugs. 2015;13(7):4310-4330.
[91] Dong L-Y, Jin J, Lu G, Kang X-L. Astaxanthin attenuates the apoptosis of retinal ganglion cells in db/db mice by inhibition of oxidative stress. Mar. Drugs. 2013;11(3):960-974.
[92] Guo S-X, Zhou H-L, Huang C-L, You C-G, Fang Q, Wu P, Wang X-G, Han C-M. Astaxanthin attenuates early acute kidney injury following severe burns in rats by ameliorating oxidative stress and mitochondrial-related apoptosis. Mar. Drugs. 2015;13(4):2105-2123.
[93] Zhang X-S, Zhang X, Wu Q, Li W, Zhang Q-R, Wang C-X, Zhou X-M, Li H, Shi J-X, Zhou M-L. Astaxanthin alleviates early brain injury following subarachnoid hemorrhage in rats: possible involvement of Akt/bad signaling. Mar. Drugs. 2014;12(8):4291-4310.
[94] Kavitha K, Kowshik J, Kishore TKK, Baba AB, Nagini S. Astaxanthin inhibits NF-[kappa]B and Wnt/[beta]-catenin signaling pathways via inactivation of Erk/MAPK and PI3K/Akt to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim. et Biophys. Acta (BBA)-Gen. Subjects. 2013;1830(10):4433-4444.
[95] Yang Y, Bae M, Kim B, Park Y-K, Koo SI, Lee J-Y. Astaxanthin prevents and reverses the activation of mouse primary hepatic stellate cells. J. Nutr. Biochem. 2016;29:21-26.
[96] Wolf AM, Asoh S, Hiranuma H, Ohsawa I, Iio K, Satou A, Ishikura M, Ohta S. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J. Nutr. Biochem. 2010;21(5):381-389.
[97] Campoio T, Oliveira F, Otton R. Oxidative stress in human lymphocytes treated with fatty acid mixture: role of carotenoid astaxanthin. Toxicol. Vitr. 2011;25(7):1448-1456.
[98] Gross GJ, Lockwood SF. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax(TM)). Life Sci. 2004;75(2):215-224.
[99] Marin DP, Bolin AP, Macedo Rd.C.S, Sampaio SC, Otton R. ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int. Immunopharmacol. 2011;11(1):103-109.
[100] Otton R, Marin DP, Bolin AP, dos Santos Rd.C.M, Polotow TG, Sampaio SC, de Barros MP. Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats. Chem. Biol. Interact. 2010;186(3):306-315.
[101] Song X, Wang B, Lin S, Jing L, Mao C, Xu P, Lv C, Liu W, Zuo J. Astaxanthin inhibits apoptosis in alveolar epithelial cells type II in vivo and in vitro through the ROS-dependent mitochondrial signalling pathway. J. Cell. Mol. Med. 2014;18(11):2198-2212.
[102] Haines DD, Varga B, Bak I, Juhasz B, Mahmoud FF, Kalantari H, Gesztelyi R, Lekli I, Czompa A, Tosaki A. Summative interaction between astaxanthin, Ginkgo biloba extract (EGb761) and vitamin C in suppression of respiratory inflammation: a comparison with ibuprofen. Phytother. Res. 2011;25(1):128-136.
[103] Ryu SK, King TJ, Fujioka K, Pattison J, Pashkow FJ, Tsimikas S. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR-/- and ApoE-/- mice. Atherosclerosis. 2012;222(1):99-105.
[104] Hanusch M, Stahl W, Schulz WA, Sies H. Induction of gap junctional communication by 4-oxoretinoic acid generated from its precursor canthaxanthin. Arch. Biochem. Biophys. 1995;317(2):423-428.
[105] Daubrawa F, Sies H, Stahl W. Astaxanthin diminishes gap junctional intercellular communication in primary human fibroblasts. J. Nutr. 2005;135(11):2507-2511.
[106] Kim JH, Park J-J, Lee BJ, Joo MK, Chun HJ, Lee SW, Bak Y-T. Astaxanthin inhibits proliferation of human gastric cancer cell lines by interrupting cell cycle progression. Gut Liver. 2016;10(3):369-374.
[107] Chen Y-T, Kao C-J, Huang H-Y, Huang S-Y, Chen C-Y, Lin Y-S, Wen Z-H, Wang H.-M.D. Astaxanthin reduces MMP expressions, suppresses cancer cell migrations, and triggers apoptotic caspases of in vitro and in vivo models in melanoma. J. Funct. Foods. 2017;31:20-31.
[108] Palozza P, Torelli C, Boninsegna A, Simone R, Catalano A, Mele MC, Picci N. Growth-inhibitory effects of the astaxanthin-rich alga Haematococcus pluvialis in human colon cancer cells. Cancer Lett. 2009;283(1):108-117.
[109] Yasui Y, Hosokawa M, Mikami N, Miyashita K, Tanaka T. Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem. Biol. Interact. 2011;193(1):79-87.
[110] Kurihara H, Koda H, Asami S, Kiso Y, Tanaka T. Contribution of the antioxidative property of astaxanthin to its protective effect on the promotion of cancer metastasis in mice treated with restraint stress. Life Sci. 2002;70(21):2509-2520.
[111] Tripathi D, Jena G. Astaxanthin inhibits cytotoxic and genotoxic effects of cyclophosphamide in mice germ cells. Toxicology. 2008;248(2):96-103.
[112] Liao K-S, Wei C-L, Chen J-C, Zheng H-Y, Chen W-C, Wu C-H, Wang T-J, Peng Y-S, Chang P-Y, Lin Y-W. Astaxanthin enhances pemetrexed-induced cytotoxicity by downregulation of thymidylate synthase expression in human lung cancer cells. Regul. Toxicol. Pharmacol. 2016;81:353-361.
[113] Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, Hirose Y, Ohnishi M. Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J. Cell. Biochem. 1997;67(S27):35-41.
[114] Tanaka T, Makita H, Ohnishi M, Mori H, Satoh K, Hara A. Chemoprevention of rat oral carcinogenesis by naturally occurring xanthophylls, astaxanthin and canthaxanthin. Cancer research. 1995;55(18):4059-4064.
[115] Tanaka T, Morishita Y, Suzui M, Kojima T, Okumura A, Mori H. Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin. Carcinogenesis. 1994;15(1):15-19.
[116] Nakao R, Nelson OL, Park JS, Mathison BD, Thompson PA, Chew BP. Effect of dietary astaxanthin at different stages of mammary tumor initiation in BALB/c mice. Anticancer Res. 2010;30(6):2171-2175.
[117] Xu Y, Zhang J, Jiang W, Zhang S. Astaxanthin induces angiogenesis through Wnt/[beta]-catenin signaling pathway. Phytomedicine. 2015;22(7-8):744-751.
[118] Tripathi D, Jena G. Astaxanthin intervention ameliorates cyclophosphamide-induced oxidative stress, DNA damage and early hepatocarcinogenesis in rat: role of Nrf2, p53, p38 and phase-II enzymes. Mutat. Res. Toxicol. Environ. Mutagen. 2010;696(1):69-80.
[119] Yuri T, Yoshizawa K, Emoto Y, Kinoshita Y, Yuki M, Tsubura A. Effects of dietary xanthophylls, canthaxanthin and astaxanthin on N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. In Vivo. 2016;30(6):795-800.
[120] Nagendraprabhu P, Sudhandiran G. Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest. New Drugs. 2011;29(2):207-224.
[121] Manivasagan P, Bharathiraja S, Santha Moorthy M, Mondal S, Seo H, Dae Lee K, Oh J. Marine natural pigments as potential sources for therapeutic applications. Crit. Rev. Biotechnol. 2017;1-17.
[122] Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants-an update. J. Diabetes Metab. Disord. 2013;12(1):28.
[123] Fakhri S, Mohammadi B, Jalili R, Hajialyani M, Bahrami G. Screening and confirmation of different synthetic adulterants in slimming products. Screening. 11 (2), 2018.
[124] Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci. 2007;56(12):615-621.
[125] Bhuvaneswari S, Arunkumar E, Viswanathan P, Anuradha CV. Astaxanthin restricts weight gain, promotes insulin sensitivity and curtails fatty liver disease in mice fed a obesity-promoting diet. Process. Biochem. 2010;45(8):1406-1414.
[126] Yang Y, Pham TX, Wegner CJ, Kim B, Ku CS, Park Y-K, Lee J-Y. Astaxanthin lowers plasma TAG concentrations and increases hepatic antioxidant gene expression in diet-induced obesity mice. Br. J. Nutr. 2014;112(11):1797-1804.
[127] Aoi W, Naito Y, Takanami Y, Ishii T, Kawai Y, Akagiri S, Kato Y, Osawa T, Yoshikawa T. Astaxanthin improves muscle lipid metabolism in exercise via inhibitory effect of oxidative CPT I modification. Biochem. Biophys. Res. Commun. 2008;366(4):892-897.
[128] Ikeuchi M, Koyama T, Takahashi J, Yazawa K. Effects of astaxanthin in obese mice fed a high-fat diet. Biosci. Biotechnol. Biochem. 2007;71(4):893-899.
[129] Aoi W, Naito Y, Yoshikawa T. Potential Role of Oxidative Protein Modification in Energy Metabolism in Exercise, Lipid Hydroperoxide-Derived Modification of Biomolecules. 2014. Springer. 175-187.
[130] Inoue M, Tanabe H, Matsumoto A, Takagi M, Umegaki K, Amagaya S, Takahashi J. Astaxanthin functions differently as a selective peroxisome proliferator-activated receptor [gamma] modulator in adipocytes and macrophages. Biochem. Pharmacol. 2012;84(5):692-700.
[131] Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008;101(10):S58-S68.
[132] Goldstein L, Brown S. The low-density lipoprotein pathway and its relation to atherosclerosis. Annu. Rev. Biochem. 1977;46(1):897-930.
[133] Kishimoto Y, Yoshida H, Kondo K. Potential anti-atherosclerotic properties of astaxanthin. Mar. Drugs. 2016;14(2):35.
[134] Palozza P, Barone E, Mancuso C, Picci N. The protective role of carotenoids against 7-keto-cholesterol formation in solution. Mol. Cell. Biochem. 2008;309(1-2):61.
[135] Li W, Hellsten A, Jacobsson LS, Blomqvist HM, Olsson AG, Yuan X-M. Alpha-tocopherol and astaxanthin decrease macrophage infiltration, apoptosis and vulnerability in atheroma of hyperlipidaemic rabbits. J. Mol. Cell. Cardiol. 2004;37(5):969-978.
[136] Kishimoto Y, Tani M, Uto-Kondo H, Iizuka M, Saita E, Sone H, Kurata H, Kondo K. Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages. Eur. J. Nutr. 2010;49(2):119-126.
[137] Gross GJ, Hazen SL, Lockwood SF. Seven day oral supplementation with Cardax TM (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol. Cell. Biochem. 2006;283(1-2):23-30.
[138] Lauver DA, Lockwood SF, Lucchesi BR. Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J. Pharmacol. Exp. Ther. 2005;314(2):686-692.
[139] Chan Kc, Pen PJ, Yin Mc. Anticoagulatory and antiinflammatory effects of astaxanthin in diabetic rats. J. Food Sci. 77 (2), 2012.
[140] Nakagawa K, Kiko T, Miyazawa T, Burdeos GC, Kimura F, Satoh A, Miyazawa T. Antioxidant effect of astaxanthin on phospholipid peroxidation in human erythrocytes. Br. J. Nutr. 2011;105(11):1563-1571.
[141] Hussein G, Nakamura M, Zhao Q, Iguchi T, Goto H, Sankawa U, Watanabe H. Antihypertensive and neuroprotective effects of astaxanthin in experimental animals. Biol. Pharm. Bull. 2005;28(1):47-52.
[142] Monroy-Ruiz J, Sevilla M.-A, Carron R, Montero M-J. Astaxanthin-enriched-diet reduces blood pressure and improves cardiovascular parameters in spontaneously hypertensive rats. Pharmacol. Res. 2011;63(1):44-50.
[143] Hussein G, Goto H, Oda S, Iguchi T, Sankawa U, Matsumoto K, Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: II. Vascular reactivity and hemorheology in spontaneously hypertensive rats. Biol. Pharm. Bull. 2005;28(6):967-971.
[144] Preuss HG, Echard B, Bagchi D, Perricone NV, Yamashita E. Astaxanthin lowers blood pressure and lessens the activity of the renin-angiotensin system in Zucker Fatty Rats. J. Funct. Foods. 2009;1(1):13-22.
[145] Hussein G, Goto H, Oda S, Sankawa U, Matsumoto K, Watanabe H. Antihypertensive potential and mechanism of action of astaxanthin: III. Antioxidant and histopathological effects in spontaneously hypertensive rats. Biol. Pharm. Bull. 2006;29(4):684-688.
[146] Zhang J, Wang Q-z, Zhao S-h, X. Ji, Qiu J, Wang J, Zhou Y, Cai Q, Zhang J, Gao H-q. Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: partially by activating SIRT1. Biochim. et Biophys. Acta (BBA)-Gen. Subj. 2017;1861(7):1715-1728.
[147] Khan SK, Malinski T, Mason RP, Kubant R, Jacob RF, Fujioka K, Denstaedt SJ, King TJ, Jackson HL, Hieber AD. Novel astaxanthin prodrug (CDX-085) attenuates thrombosis in a mouse model. Thromb. Res. 2010;126(4):299-305.
[148] Xu J, Gao H, Zhang L, Chen C, Yang W, Deng Q, Huang Q, Huang F. A combination of flaxseed oil and astaxanthin alleviates atherosclerosis risk factors in high fat diet fed rats. Lipids Health Dis. 2014;13(1):63.
[149] Saito M, Yoshida K, Saito W, Fujiya A, Ohgami K, Kitaichi N, Tsukahara H, Ishida S, Ohno S. Astaxanthin increases choroidal blood flow velocity. Graefe's Arch. Clin. Exp. Ophthalmol. 2012;250(2):239-245.
[150] Sasaki Y, Kobara N, Higashino S, Giddings JC, Yamamoto J. Astaxanthin inhibits thrombosis in cerebral vessels of stroke-prone spontaneously hypertensive rats. Nutr. Res. 2011;31(10):784-789.
[151] Hussein G, Nakagawa T, Goto H, Shimada Y, Matsumoto K, Sankawa U, Watanabe H. Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci. 2007;80(6):522-529.
[152] Jyonouchi H, Hill RJ, Tomita Y, Good RA. Studies of Immunomodulating Actions of Carotenoids. I. Effects of [beta]-carotene and Astaxanthin on Murine Lymphocyte Functions and Cell Surface Marker Expression in in Vitro Culture System; 1991.
[153] Jyonouchi H, Zhang L, Gross M, Tomita Y. Immunomodulating Actions of Carotenoids: Enhancement of in Vivo and in Vitro Antibody Production to T-Dependent Antigens; 1994.
[154] Park JS, Mathison BD, Hayek MG, Massimino S, Reinhart GA, Chew BP. Astaxanthin stimulates cell-mediated and humoral immune responses in cats. Vet. Immunol. Immunopathol. 2011;144(3-4):455-461.
[155] Lin K-H, Lin K-C, Lu W-J, Thomas P-A, Jayakumar T, Sheu J-R. Astaxanthin, a carotenoid, stimulates immune responses by enhancing ifn-[gamma] and il-2 secretion in primary cultured lymphocytes in vitro and ex vivo. Int. J. Mol. Sci. 2015;17(1):44.
[156] Jyonouchi H, Sun S, Mizokami M, Gross MD. Effects of various carotenoids on cloned, effector-stage T-helper cell activity. Nutr. Cancer. 1996;26(3):313-324.
[157] Jyonouchi H, Sun S, Gross M. Effect of carotenoids on in vitro immunoglobulin production by human peripheral blood mononuclear cells: astaxanthin, a carotenoid without vitamin a activity, enhances in vitro immunoglobulin production in response to at-dependent stimulant and antigen. Nutr. Cancer. 1995;23(2):171-183.
[158] S. Asami, Z.-b. Yang, E. Yamashita, H. Otoze, Anti-stress composition, Google Patents, 2001.
[159] Chew BP, Park JS. Carotenoid action on the immune response. J. Nutr. 2004;134(1):257S-261S.
[160] Uchiyama K, Naito Y, Hasegawa G, Nakamura N, Takahashi J, Yoshikawa T. Astaxanthin protects [beta]-cells against glucose toxicity in diabetic db/db mice. Redox Rep. 2002;7(5):290-293.
[161] Leite M, De Lima A, Massuyama M, Otton R. In vivo astaxanthin treatment partially prevents antioxidant alterations in dental pulp from alloxan-induced diabetic rats. Int. Endod. J. 2010;43(11):959-967.
[162] Spiller GA, Dewell A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: a randomized clinical trial. J. Med. Food. 2003;6(1):51-56.
[163] Leite MF, de Lima AM, Massuyama MM, Otton R. Astaxanthin restores the enzymatic antioxidant profile in salivary gland of alloxan-induced diabetic rats. Arch. Oral Biol. 2010;55(7):479-485.
[164] Nishigaki I, Rajendran P, Venugopal R, Ekambaram G, Sakthisekaran D, Nishigaki Y. Cytoprotective role of astaxanthin against glycated protein/iron chelate-induced toxicity in human umbilical vein endothelial cells. Phytother. Res. 2010;24(1):54-59.
[165] Bhuvaneswari S, Anuradha CV. Astaxanthin prevents loss of insulin signaling and improves glucose metabolism in liver of insulin resistant mice. Can. J. Physiol. Pharmacol. 2012;90(11):1544-1552.
[166] Ishiki M, Nishida Y, Ishibashi H, Wada T, Fujisaka S, Takikawa A, Urakaze M, Sasaoka T, Usui I, Tobe K. Impact of divergent effects of astaxanthin on insulin signaling in L6 cells. Endocrinology. 2013;154(8):2600-2612.
[167] Naito Y, Uchiyama K, Aoi W, Hasegawa G, Nakamura N, Yoshida N, Maoka T, Takahashi J, Yoshikawa T. Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db mice. Biofactors. 2004;20(1):49-59.
[168] Kim YJ, Kim YA, Yokozawa T. Protection against oxidative stress, inflammation, and apoptosis of high-glucose-exposed proximal tubular epithelial cells by astaxanthin. J. Agric. Food Chem. 2009;57(19):8793-8797.
[169] Atarashi M, Manabe Y, Kishimoto H, Sugawara T, Osakabe M. Antioxidant protection by astaxanthin in the citrus red mite (Acari: Tetranychidae). Environ. Entomol. 2017;46(5):1143-1150.
[170] Chen J-T, Kotani K. Astaxanthin as a potential protector of liver function: a review. J. Clin. Med. Res. 2016;8(10):701-704.
[171] Kang J, Kim S, Kim H. Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CCl4-treated rats. Methods Find. Exp. Clin. Pharmacol. 2001;23(2):79-84.
[172] Rao AR, Sarada R, Shylaja MD, Ravishankar G. Evaluation of hepatoprotective and antioxidant activity of astaxanthin and astaxanthin esters from microalga-Haematococcus pluvialis. J. Food Sci. Technol. 2015;52(10):6703-6710.
[173] Takaki A, Kawai D, Yamamoto K. Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). Int. J. Mol. Sci. 2013;14(10):20704-20728.
[174] Shen M, Chen K, Lu J, Cheng P, Xu L, Dai W, Wang F, He L, Zhang Y, Chengfen W. Protective effect of astaxanthin on liver fibrosis through modulation of TGF-1 expression and autophagy. Mediators Inflamm. 2014; 2014.
[175] Li J, Dai W, Xia Y, Chen K, Li S, Liu T, Zhang R, Wang J, Lu W, Zhou Y. Astaxanthin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells via Inhibition of NF-[kappa]B P65 and Wnt/[beta]-catenin in vitro. Mar. Drugs. 2015;13(10):6064-6081.
[176] Li J, Wang F, Xia Y, Dai W, Chen K, Li S, Liu T, Zheng Y, Wang J, Lu W. Astaxanthin pretreatment attenuates hepatic ischemia reperfusion-induced apoptosis and autophagy via the ROS/MAPK pathway in mice. Mar. Drugs. 2015;13(6):3368-3387.
[177] Song X-d, Zhang J-j, Wang M-r, Liu W-b, Gu X-b, Lv C-j. Astaxanthin induces mitochondria-mediated apoptosis in rat hepatocellular carcinoma CBRH-7919 cells. Biol. Pharm. Bull. 2011;34(6):839-844.
[178] Song X, Wang M, Zhang L, Zhang J, Wang X, Liu W, Gu X, Lv C. Changes in cell ultrastructure and inhibition of JAK1/STAT3 signaling pathway in CBRH-7919 cells with astaxanthin. Toxicol. Mech. Methods. 2012;22(9):679-686.
[179] Yang Y, Kim B, Park Y-K, Koo SI, Lee J-Y. Astaxanthin prevents TGF[beta]1-induced pro-fibrogenic gene expression by inhibiting Smad3 activation in hepatic stellate cells. Biochim. et Biophys. Acta (BBA)-Gen. Subj. 2015;1850(1):178-185.
[180] Li J, Xia Y, Liu T, Wang J, Dai W, Wang F, Zheng Y, Chen K, Li S, Abudumijiti H. Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis. PloS One. 2015;10(3), e0120440
[181] Polotow TG, Vardaris CV, Mihaliuc AR, Goncalves MS, Pereira B, Ganini D, Barros MP. Astaxanthin supplementation delays physical exhaustion and prevents redox imbalances in plasma and soleus muscles of Wistar rats. Nutrients. 2014;6(12):5819-5838.
[182] Jia Y, Wu C, Kim J, Kim B, Lee S-J. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt. J. Nutr. Biochem. 2016;28:9-18.
[183] Corrigan JD, Selassie AW, Orman JAL. The epidemiology of traumatic brain injury. J. Head Trauma Rehabil. 2010;25(2):72-80.
[184] Shen H, Kuo C-C, Chou J, Delvolve A, Jackson SN, Post J, Woods AS, Hoffer BJ, Wang Y, Harvey BK. Astaxanthin reduces ischemic brain injury in adult rats. The FASEB journal. 2009;23(6):1958-1968.
[185] Ying C-j, Zhang F, Zhou X-y, Hu X-t, Chen J, Wen X-r, Sun Y, Zheng K-y, Tang R-x, Song Y-j. Anti-inflammatory effect of astaxanthin on the sickness behavior induced by diabetes mellitus. Cell. Mol. Neurobiol. 2015;35(7):1027-1037.
[186] Fakhri S, Abbaszadeh F, Jorjani M. Astaxanthin as a potent neuroprotective agent. Pajoohande. 2017;21(6):356-363.
[187] Masoudi A, Dargahi L, Abbaszadeh F, Pourgholami MH, Asgari A, Manoochehri M, Jorjani M. Neuroprotective effects of astaxanthin in a rat model of spinal cord injury. Behav. Brain Res. 2017;329:104-110.
[188] Xu L, Zhu J, Yin W, Ding X. Astaxanthin improves cognitive deficits from oxidative stress, nitric oxide synthase and inflammation through upregulation of PI3K/Akt in diabetes rat. Int. J. Clin. Exp. Pathol. 2015;8(6):6083.
[189] Zhang X-S, Zhang X, Zhou M-L, Zhou X-M, Li N, Li W, Cong Z-X, Sun Q, Zhuang Z, Wang C-X. Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage. J. Neurosurg. 2014;121(1):42-54.
[190] Zhang X-S, Zhang X, Wu Q, Li W, Wang C-X, Xie G-B, Zhou X-M, Shi J-X, Zhou M-L. Astaxanthin offers neuroprotection and reduces neuroinflammation in experimental subarachnoid hemorrhage. J. Surg. Res. 2014;192(1):206-213.
[191] Chang C-S, Chang C-L, Lai G-H. Reactive oxygen species scavenging activities in a chemiluminescence model and neuroprotection in rat pheochromocytoma cells by astaxanthin, beta-carotene, and canthaxanthin. Kaohsiung J. Med. Sci. 2013;29(8):412-421.
[192] Zhang Y, Wang W, Hao C, Mao X, Zhang L. Astaxanthin protects PC12 cells from glutamate-induced neurotoxicity through multiple signaling pathways. J. Funct. Foods. 2015;16:137-151.
[193] Yan T, Zhao Y, Zhang X, Lin X. Astaxanthin inhibits acetaldehyde-induced cytotoxicity in SH-SY5Y cells by modulating Akt/CREB and p38MAPK/ERK signaling pathways. Mar. Drugs. 2016;14(3):56.
[194] Wen X, Huang A, Hu J, Zhong Z, Liu Y, Li Z, Pan X, Liu Z. Neuroprotective effect of astaxanthin against glutamate-induced cytotoxicity in HT22 cells: involvement of the Akt/GSK-3[beta] pathway. Neuroscience. 2015;303:558-568.
[195] Kim J-H, Nam S-W, Kim B-W, Choi W, Lee J-H, Kim W-J, Choi Y-H. Astaxanthin improves stem cell potency via an increase in the proliferation of neural progenitor cells. Int. J. Mol. Sci. 2010;11(12):5109-5119.
[196] Lee D-H, Kim C-S, Lee YJ. Astaxanthin protects against MPTP/MPP+-induced mitochondrial dysfunction and ROS production in vivo and in vitro. Food Chem. Toxicol. 2011;49(1):271-280.
[197] Ji X, Peng D, Zhang Y, Zhang J, Wang Y, Gao Y, Lu N, Tang P. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury. Brain Res. 2017;1659:88-95.
[198] Zhang X-S, Zhang X, Zhang Q-R, Wu Q, Li W, Jiang T-W, Hang C-H. Astaxanthin reduces matrix metalloproteinase-9 expression and activity in the brain after experimental subarachnoid hemorrhage in rats. Brain Res. 2015;1624:113-124.
[199] Zhou X-y, Zhang F, Hu X-t, Chen J, Tang R-x, Zheng K-y, Song Y-j. Depression can be prevented by astaxanthin through inhibition of hippocampal inflammation in diabetic mice. Brain Res. 2017;1657:262-268.
[200] Zhou X, Zhang F, Hu X, Chen J, Wen X, Sun Y, Liu Y, Tang R, Zheng K, Song Y. Inhibition of inflammation by astaxanthin alleviates cognition deficits in diabetic mice. Physiol. Behav. 2015;151:412-420.
[201] Al-Amin MM, Reza HM, Saadi HM, Mahmud W, Ibrahim AA, Alam MM, Kabir N, Saifullah A, Tropa ST, Quddus AR. Astaxanthin ameliorates aluminum chloride-induced spatial memory impairment and neuronal oxidative stress in mice. Eur. J. Pharmacol. 2016;777:60-69.
[202] Sifi N, Martin-Eauclaire M-F, Laraba-Djebari F. K+ channel blocker-induced neuroinflammatory response and neurological disorders: immunomodulatory effects of astaxanthin. Inflamm. Res. 2016;65(8):623-634.
[203] Zhang M, Cui Z, Cui H, Cao Y, Wang Y, Zhong C. Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice. BMC Neurosci. 2016;17(1):60.
[204] Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the-art, current prospects, and future challenges. Bone. 2016;85:81-90.
[205] Chen W-P, Xiong Y, Shi Y-X, Hu P-F, Bao J-P, Wu L-D. Astaxanthin reduces matrix metalloproteinase expression in human chondrocytes. Int. Immunopharmacol. 2014;19(1):174-177.
[206] Kimble LL, Mathison BD, Chew BP. Astaxanthin mediates inflammation biomarkers associated with arthritis in human chondrosarcoma cells induced with Interleukin-1[beta]. Am. J. Adv. Food Sci. Technol. 2013;2:37-51.
[207] Kim JH, Nam S-W, Kim BW, Kim W-J, Choi YH. Astaxanthin improves the proliferative capacity as well as the osteogenic and adipogenic differentiation potential in neural stem cells. Food Chem. Toxicol. 2010;48(6):1741-1745.
[208] Choi HD, Youn YK, Shin WG. Positive effects of astaxanthin on lipid profiles and oxidative stress in overweight subjects. Plant Foods Hum. Nutr. 2011;66(4):363-369.
[209] Seki T, Sueki H, Kono H, Kaoru S, Eiji Y. Effects of astaxanthin from haematococcus pluvialis on human skin. France Journal. 2001;12:98-103.
[210] Lyons NM, O'Brien NM. Modulatory effects of an algal extract containing astaxanthin on UVA-irradiated cells in culture. J. Dermatol. Sci. 2002;30(1):73-84.
[211] Suganuma K, Nakajima H, Ohtsuki M, Imokawa G. Astaxanthin attenuates the UVA-induced up-regulation of matrix-metalloproteinase-1 and skin fibroblast elastase in human dermal fibroblasts. J. Dermatol. Sci. 2010;58(2):136-142.
[212] Tominaga K, Hongo N, Karato M, Yamashita E. Cosmetic benefits of astaxanthin on humans subjects. Acta Biochim. Pol. 2012;59(1):43.
[213] Hama S, Takahashi K, Inai Y, Shiota K, Sakamoto R, Yamada A, Tsuchiya H, Kanamura K, Yamashita E, Kogure K. Protective effects of topical application of a poorly soluble antioxidant astaxanthin liposomal formulation on ultraviolet-induced skin damage. J. Pharm. Sci. 2012;101(8):2909-2916.
[214] Santos SD, Cahu TB, Firmino GO, de Castro CC, Carvalho Jr LB, Bezerra RS, Jose Filho LL. Shrimp waste extract and astaxanthin: rat alveolar macrophage, oxidative stress and inflammation. J. Food Sci. 77 (7), 2012.
[215] Yoon H-S, Cho HH, Cho S, Lee S-R, Shin M-H, Chung JH. Supplementing with dietary astaxanthin combined with collagen hydrolysate improves facial elasticity and decreases matrix Metalloproteinase-1 and-12 expression: a comparative study with placebo. J. Med. Food. 2014;17(7):810-816.
[216] Yoshihisa Y, Andoh T, Matsunaga K, Rehman MU, Maoka T, Shimizu T. Efficacy of astaxanthin for the treatment of atopic dermatitis in a murine model. PloS One. 11. 3. 2016. e0152288.
[217] Mizuta M, Hirano S, Hiwatashi N, Tateya I, Kanemaru Si, Nakamura T, Ito J. Effect of astaxanthin on vocal fold wound healing. Laryngoscope. 124 (1), 2014.
[218] Yoshihisa Y, Shimizu T. Astaxanthin, a xanthophyll carotenoid, inhibits ultraviolet-induced apoptosis in keratinocytes. Exp. Dermatol. 2014;23(3):178-183.
[219] Yamashita E. The effects of a dietary supplement containing astaxanthin on skin condition. Food Style 21. 2005;9(9):72.
[220] Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S. Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year. Ophthalmology. 2008;115(2):324-333, e2.
[221] Sangeetha R, Baskaran V. Retinol-deficient rats can convert a pharmacological dose of astaxanthin to retinol: antioxidant potential of astaxanthin, lutein, and [beta]-carotene. Can. J. Physiol. Pharmacol. 2010;88(10):977-985.
[222] Otsuka T, Shimazawa M, Inoue Y, Nakano Y, Ojino K, Izawa H, Tsuruma K, Ishibashi T, Hara H. Astaxanthin protects against retinal damage: evidence from in vivo and in vitro retinal ischemia and reperfusion models. Curr. Eye Res. 2016;41(11):1465-1472.
[223] Otsuka T, Shimazawa M, Nakanishi T, Ohno Y, Inoue Y, Tsuruma K, Ishibashi T, Hara H. The protective effects of a dietary carotenoid, astaxanthin, against light-induced retinal damage. J. Pharmacol. Sci. 2013;123(3):209-218.
[224] Izumi-Nagai K, Nagai N, Ohgami K, Satofuka S, Ozawa Y, Tsubota K, Ohno S, Oike Y, Ishida S. Inhibition of choroidal neovascularization with an anti-inflammatory carotenoid astaxanthin. Invest. Ophthalmol. Vis. Sci. 2008;49(4):1679-1685.
[225] Cort A, Ozturk N, Akpinar D, Unal M, Yucel G, Ciftcioglu A, Yargicoglu P, Aslan M. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul. Toxicol. Pharmacol. 2010;58(1):121-130.
[226] Nakajima H, Fukazawa K, Wakabayashi Y, Wakamatsu K, Senda K, Imokawa G. Abrogating effect of a xanthophyll carotenoid astaxanthin on the stem cell factor-induced stimulation of human epidermal pigmentation. Arch. Dermatol. Res. 2012;304(10):803-816.
[227] Yeh P-T, Huang H-W, Yang C-M, Yang W-S, Yang C-H. Astaxanthin inhibits expression of retinal oxidative stress and inflammatory mediators in streptozotocin-induced diabetic rats. PloS One. 2016;11(1), e0146438
[228] Fry AC, Schilling BK, Chiu LZ, Hori N, Weiss LW. Fiber type-specific responses to perceptions of delayed onset muscle soreness with astaxanthin supplementation. Med. Sci. Sports Exerc. 2004;36(5):S175.
[229] Sawaki K, Yoshigi H, Aoki K, Koikawa N, Azumane A, Kaneko K, Yamaguchi M. Sports performance benefits from taking natural astaxanthin characterized by visual acuity and muscle fatigue improvements in humans. J. Clin. Ther. Med. 2002;18(9):73-88.
[230] Earnest CP, Lupo M, White K, Church T. Effect of astaxanthin on cycling time trial performance. Int. J. Sports Med. 2011;32(11):882-888.
[231] Malmstena CL, Lignellb A. Dietary supplementation with astaxanthin-rich algal meal improves strength endurance-a double blind placebo controlled study on male students-. Carotenoid Sci. 2008;13:20-22.
[232] Yamashita E. Astaxanthin and sports performance. Food Style. 2011;21:15.
[233] Djordjevic B, Baralic I, Kotur-Stevuljevic J, Stefanovic A, Ivanisevic J, Radivojevic N, Andjelkovic M, Dikic N. Effect of astaxanthin supplementation on muscle damage and oxidative stress markers in elite young soccer players. J. Sports Med. Phys. Fitness. 2012;52(4):382-392.
[234] Yoshihara T, Sugiura T, Naito H. Astaxanthin supplementation attenuates disuse muscle atrophy and myonuclear apoptosis in rat skeletal muscle. Musculoskelet. Regen. 2016; 2.
[235] Liu PH, Aoi W, Takami M, Terajima H, Tanimura Y, Naito Y, Itoh Y, Yoshikawa T. The astaxanthin-induced improvement in lipid metabolism during exercise is mediated by a PGC-1[alpha] increase in skeletal muscle. J. Clin. Biochem. Nutr. 2014;54(2):86-89.
[236] Shibaguchi T, Yamaguchi Y, Miyaji N, Yoshihara T, Naito H, Goto K, Ohmori D, Yoshioka T, Sugiura T. Astaxanthin intake attenuates muscle atrophy caused by immobilization in rats. Physiol. Rep. 4 (15), 2016.
[237] Eskenazi B, Kidd S, Marks A, Sloter E, Block G, Wyrobek A. Antioxidant intake is associated with semen quality in healthy men. Hum. Reprod. 2005;20(4):1006-1012.
[238] Garrido N, Meseguer M, Simon C, Pellicer A, Remohi J. Pro-oxidative and anti-oxidative imbalance in human semen and its relation with male fertility. Asian J. Androl. 2004;6(1):59-66.
[239] Sanocka D, Kurpisz M. Reactive oxygen species and sperm cells. Reprod. Biol. Endocrinol. 2004;2(1):12.
[240] Fang Y, Zhong R, Chen L, Feng C, Sun H, Zhou D. Effects of astaxanthin supplementation on the sperm quality and antioxidant capacity of ram semen during liquid storage. Small Rumin. Res. 2015;130:178-182.
[241] Andrisani A, Dona G, Tibaldi E, Brunati AM, Sabbadin C, Armanini D, Alvisi G, Gizzo S, Ambrosini G, Ragazzi E. Astaxanthin improves human sperm capacitation by inducing lyn displacement and activation. Mar. Drugs. 2015;13(9):5533-5551.
[242] Wang J-Y, Lee Y-J, Chou M-C, Chang R, Chiu C-H, Liang Y-J, Wu L-S. Astaxanthin protects steroidogenesis from hydrogen peroxide-induced oxidative stress in mouse Leydig cells. Mar. Drugs. 2015;13(3):1375-1388.
[243] Vega K, Edwards J, Beilstein P. Subchronic (13-week) toxicity and prenatal developmental toxicity studies of dietary astaxanthin in rats. Regul. Toxicol. Pharmacol. 2015;73(3):819-828.
[244] Marvizon JCG, McRoberts JA, Ennes HS, Song B, Wang X, Jinton L, Corneliussen B, Mayer EA. Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and localization. J. Comp. Neurol. 2002;446(4):325-341.
[245] Yezierski R. Pathophysiology and animal models of spinal cord injury pain. Prog. Pain Res. Manag. 2002;23:117-136.
[246] Gorman AL, Yu C-G, Ruenes GR, Daniels L, Yezierski RP. Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J. Pain. 2001;2(4):229-240.
[247] Yu C-G, Fairbanks CA, Wilcox GL, Yezierski RP. Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats. J. Pain. 2003;4(3):129-140.
[248] Hains BC, Waxman SG. Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog. Brain Res. 2007;161:195-203.
[249] Lampert A, Hains BC, Waxman SG. Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury. Exp. Brain Res. 2006;174(4):660-666.
[250] POLLOCK LJ, BROWN M, BOSHES B, FINKELMAN I, CHOR H, ARIEFF AJ, FINKLE JR. Pain below the level of injury of the spinal cord. AMA Arch. Neurol. Psychiatry. 1951;65(3):319-322.
[251] Ji R-R, Woolf CJ. Neuronal plasticity and signal transduction in nociceptive neurons: implications for the initiation and maintenance of pathological pain. Neurobiol. Dis. 2001;8(1):1-10.
[252] D'Angelo R, Morreale A, Donadio V, Boriani S, Maraldi N, Plazzi G, Liguori R. Neuropathic pain following spinal cord injury: what we know about mechanisms, assessment and management. Eur. Rev. Med. Pharmacol. Sci. 2013;17(23):3257-3261.
[253] Lerch JK, Puga DA, Bloom O, Popovich PG. Glucocorticoids and Macrophage Migration Inhibitory Factor (MIF) Are Neuroendocrine Modulators of Inflammation and Neuropathic Pain After Spinal Cord Injury, Semin. Immunol. 2014. Elsevier. 409-414.
[254] Baastrup C, Finnerup NB. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 2008;22(6):455-475.
[255] Attal N, Cruccu G, Baron Ra, Haanpaa M, Hansson P, Jensen TS, Nurmikko T. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur. J. Neurol. 2010;17(9):1113.
[256] Avila-Martin G, Galan-Arriero I, Gomez-Soriano J, Taylor J. Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: translational application for paralysis, spasticity and pain. PloS One. 6. 10. 2011. e26107.
[257] Siddall PJ, Cousins M, Otte A, Griesing T, Chambers R, Murphy T. Pregabalin in central neuropathic pain associated with spinal cord injury A placebo-controlled trial. Neurology. 2006;67(10):1792-1800.
[258] Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci. 1995;18(2):57-58.
[259] Choi DW. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 1987;7(2):369-379.
[260] Yamagishi R, Aihara M. Neuroprotective effect of astaxanthin against rat retinal ganglion cell death under various stresses that induce apoptosis and necrosis. Mol. Vis. 2014;20:1796-1805.
[261] Aly H, Khashaba MT, El-Ayouty M, El-Sayed O, Hasanein BM. IL-1[beta], IL-6 and TNF-[alpha] and outcomes of neonatal hypoxic ischemic encephalopathy. Brain Dev. 2006;28(3):178-182.
[262] Aamodt SM, Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol. 1999;79:133-144.
[263] Sharma K, Sharma D, Sharma M, Sharma N, Bidve P, Prajapati N, Kalia K, Tiwari V. Astaxanthin ameliorates behavioral and biochemical alterations in in-vitro and in-vivo model of neuropathic pain. Neurosci. Lett. 2018.
[264] Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283(5398):70-74.
[265] Hetman M, Kharebava G. Survival signaling pathways activated by NMDA receptors. Curr. Top. Med. Chem. 2006;6(8):787-799.
[266] Bennett AD, Everhart AW, Hulsebosch CE. Intrathecal administration of an NMDA or a non-NMDA receptor antagonist reduces mechanical but not thermal allodynia in a rodent model of chronic central pain after spinal cord injury. Brain Res. 2000;859(1):72-82.
[267] Shi X, Leng L, Wang T, Wang W, Du X, Li J, McDonald C, Chen Z, Murphy JW, Lolis E. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity. 2006;25(4):595-606.
[268] Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, Bucala R, Weber C, Bernhagen J. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 2009;583(17):2749-2757.
[269] Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes F-J, Roger T, Calandra T, Kapurniotu A. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 2000;408(6809):211.
[270] Alexander JK, Cox GM, Tian J-B, Zha AM, Wei P, Kigerl KA, Reddy MK, Dagia NM, Sielecki T, Zhu MX. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Exp. Neurol. 2012;236(2):351-362.
[271] Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 2003;3(10):791.
[272] Roskoski R Jr. Guidelines for preparing color figures for everyone including the colorblind. Pharmacol. Res. 2017;119:240.
[273] Hussein G, Sankawa U, Goto H, Matsumoto K, Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod. 2006;69(3):443-449.
[274] Hix LM, Frey DA, McLaws MD, [script phi]sterlie M, Lockwood SF, Bertram JS. Inhibition of chemically-induced neoplastic transformation by a novel tetrasodium diphosphate astaxanthin derivative. Carcinogenesis. 2005;26(9):1634-1641.
[275] Serebruany V, Malinin A, Goodin T, Pashkow F. The in vitro effects of Xancor, a synthetic astaxanthine derivative, on hemostatic biomarkers in aspirin-naive and aspirin-treated subjects with multiple risk factors for vascular disease. Am. J. Ther. 2010;17(2):125-132.
[276] Choi HD, Kim JH, Chang MJ, Kyu-Youn Y, Shin WG. Effects of astaxanthin on oxidative stress in overweight and obese adults. Phytother. Res. 2011;25(12):1813-1818.
[277] Karppi Rissanen, Nyyssonen Kaikkonen, Olsson Voutilainen, Salonen. Effects of astaxanthin supplementation on lipid peroxidation. Int. J. Vitam. Nutr. Res. 2007;77(1):3-11.
[278] Miyawaki H, Takahashi J, Tsukahara H, Takehara I. Effects of astaxanthin on human blood rheology. J. Clin. Biochem. Nutr. 2008;43(2):69-74.
[279] Park JS, Chyun JH, Kim YK, Line LL, Chew BP. Astaxanthin decreased oxidative stress and inflammation and enhanced immune response in humans. Nutr. Metab. 2010;7(1):18.
[280] Hashimoto H, Arai K, Hayashi S, Okamoto H, Takahashi J, Chikuda M, Obara Y. Effects of astaxanthin on antioxidation in human aqueous humor. J. Clin. Biochem. Nutr. 2013;13-16.
[281] Nagaki Y, Hayasaka S, Yamada T, Hayasaka Y, Sanada M, Uonomi T. Effects of astaxanthin on accommodation, critical flicker fusion, and pattern visual evoked potential in visual display terminal workers. Afr. J. Tradit. Complement. Altern. Med. 2002;19(5):170-180.
[282] Takahashi N, Kajita M. Effects of astaxanthin on accommodative recovery. J. Clin. Ther. Med. 2005;21(4):431-436.
[283] Tsukahara H, Fukuhara I, Takehara I. Evaluation of long-term safety study of natural astaxanthin in healthy volunterrs. J. Nutr. Food. 2005;8:27-37.
|
Language: | English.
|
Document Type: | Articles.
|
Journal Subset: | Pharmacology.
|
ISSN: | 1043-6618
|
NLM Journal Code: | phc, 8907422
|
DOI Number: | https://dx.doi.org/10.1016/j.phr...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|